Dr. Soltesz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
- Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery, 2005 - 2007
- Brigham and Women's HospitalResidency, Surgery, 1998 - 2005
- Harvard Medical SchoolClass of 1998
Certifications & Licensure
- OH State Medical License 2006 - 2026
- PA State Medical License 2009 - 2016
- MA State Medical License 2001 - 2010
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Randomized Study of Organ Care System Cardiac for Preservation of Donated Hearts for Eventual Transplantation Start of enrollment: 2009 Mar 01
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Contact, Principal Investigator, Sub-Investigator
Publications & Presentations
PubMed
- 45 citationsNew Surgical Circulatory Support System Outcomes.Danny Ramzy, Edward G. Soltesz, Mark E. Anderson
ASAIO Journal. 2020-07-01 - 12 citationsOutcomes of Open Versus Endovascular Repair of Descending Thoracic and Thoracoabdominal Aortic Aneurysms.Michael Z. Tong, Matthew J. Eagleton, Eric E. Roselli, Eugene H. Blackstone, Fei Xiang
The Annals of Thoracic Surgery. 2021-05-25 - 42 citationsOpen Aortic Repair After Prior Thoracic Endovascular Aortic RepairEric E. Roselli, Mohamed Abdel-Halim, Douglas R. Johnston, Edward G. Soltesz, Roy K. Greenberg
The Annals of Thoracic Surgery. 2014-03-01
Press Mentions
- Auf Der STS-Jahrestagung Vorgestellte Umfangreiche Klinische Studie Zeigt Überlebensrate Von 79 % Bei Behandlung Mit Impella 5.5 Mit SmartAssist HerzpumpeFebruary 1st, 2021
- Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssistJanuary 29th, 2021
- Atrial Arrhythmias in LVAD Recipients Don’t Compromise Outcomes in Large Cohort StudyApril 26th, 2019
- Join now to see all
Grant Support
- Gene Therapy For Chronic Heart FailureNational Heart, Lung, And Blood Institute2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: